0001209191-21-033807.txt : 20210518 0001209191-21-033807.hdr.sgml : 20210518 20210518201203 ACCESSION NUMBER: 0001209191-21-033807 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210518 FILED AS OF DATE: 20210518 DATE AS OF CHANGE: 20210518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cheng Andrew CENTRAL INDEX KEY: 0001778307 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40407 FILM NUMBER: 21937993 MAIL ADDRESS: STREET 1: 170 HARBOR WAY, 3RD FLOOR STREET 2: C/O AKERO THERAPEUTICS, INC. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vera Therapeutics, Inc. CENTRAL INDEX KEY: 0001831828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812744449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 170 HARBOR WAY STREET 2: 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-770-0077 MAIL ADDRESS: STREET 1: 170 HARBOR WAY STREET 2: 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-18 0 0001831828 Vera Therapeutics, Inc. VERA 0001778307 Cheng Andrew C/O VERA THERAPEUTICS, INC. 170 HARBOR WAY, 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Class A Common Stock 2021-05-18 4 C 0 17488 A 17488 I See footnote Series C Preferred Stock 2021-05-18 4 C 0 17488 0.00 D Class A Common Stock 17488 0 I See footnote The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date. The shares are held of record by Andrew K. Cheng, as Trustee of the Andrew Cheng 2010 Trust UA 10-26-2010. /s/ Joseph R. Young, Attorney-in-Fact 2021-05-18